Neurocrine Biosciences, Inc. Stock Deutsche Boerse AG
Equities
NB3
US64125C1099
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
135.1 EUR | -0.35% |
|
+5.88% | +13.55% |
Jul. 09 | RBC Cuts Price Target on Neurocrine Biosciences to $136 From $141, Keeps Sector Perform Rating | MT |
Jul. 03 | ANALYST RECOMMENDATIONS : Alphabet, Nike, Nvidia, Tesla, Starbucks... | ![]() |
Sales 2024 * | 2.22B 2.04B | Sales 2025 * | 2.55B 2.34B | Capitalization | 14.81B 13.61B |
---|---|---|---|---|---|
Net income 2024 * | 432M 397M | Net income 2025 * | 673M 619M | EV / Sales 2024 * | 5.77 x |
Net cash position 2024 * | 2B 1.84B | Net cash position 2025 * | 2.72B 2.5B | EV / Sales 2025 * | 4.74 x |
P/E ratio 2024 * |
36.2
x | P/E ratio 2025 * |
23.2
x | Employees | 1,448 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.2% |
Latest transcript on Neurocrine Biosciences, Inc.
1 day | -0.37% | ||
1 week | +5.88% | ||
Current month | +4.05% | ||
1 month | +8.44% | ||
3 months | +5.43% | ||
6 months | +12.60% | ||
Current year | +13.55% |
![Extreme 127](/images/extremecours_fleche.png)
![Extreme 120.85](/images/extremecours_fleche.png)
![Extreme 118.25](/images/extremecours_fleche.png)
![Extreme 83.96](/images/extremecours_fleche.png)
![Extreme 63.54](/images/extremecours_fleche.png)
![Extreme 63.54](/images/extremecours_fleche.png)
![Extreme 9.351](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Kevin Gorman
FOU | Founder | 66 | 91-12-31 |
Director of Finance/CFO | 44 | 17-10-31 | |
Jude Onyia
CTO | Chief Tech/Sci/R&D Officer | 60 | 21-11-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Sherwin
BRD | Director/Board Member | 75 | 99-03-31 |
George Morrow
BRD | Director/Board Member | 72 | 15-09-30 |
Kevin Gorman
FOU | Founder | 66 | 91-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-11 | 135 | -0.48% | 0 |
24-07-10 | 135.6 | +3.75% | 4 |
24-07-09 | 130.7 | +2.19% | 0 |
24-07-08 | 127.9 | +0.71% | 0 |
24-07-05 | 127 | -0.35% | 0 |
Delayed Quote Deutsche Boerse AG, July 11, 2024 at 02:01 am EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.49% | 127B | |
+22.18% | 116B | |
+24.43% | 27.69B | |
-21.64% | 19.62B | |
-16.64% | 16.26B | |
-17.73% | 15.49B | |
-48.41% | 14.39B | |
+55.94% | 14.11B | |
+141.46% | 11.79B |
- Stock Market
- Equities
- NBIX Stock
- NB3 Stock